Theriva Biologics, Inc. Additional Paid in Capital, Common Stock
Theriva Biologics, Inc. (TOVX) had Additional Paid in Capital, Common Stock of $376.15 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-11
- 2026-06-30: Additional Paid in Capital, Common Stock $376.15M.
- 2026-03-31: Additional Paid in Capital, Common Stock $376.02M.
- 2025-12-31: Additional Paid in Capital, Common Stock $373.59M.
- 2025-09-30: Additional Paid in Capital, Common Stock $362.97M.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2026-06-30 | $376.15M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $376.02M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $373.59M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $362.97M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $362.46M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $355.60M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $355.50M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $355.33M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $349.67M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $346.68M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $346.54M 10-K · filed 2025-03-06 | $346.52M 10-K · filed 2024-03-25 |
| 2023-09-30 | $346.31M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $346.18M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $343.88M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $343.75M 10-K · filed 2024-03-25 | |
| 2022-09-30 | $343.62M 10-K · filed 2023-03-30 | |
| 2022-06-30 | $343.50M 10-K · filed 2023-03-30 | |
| 2022-03-31 | $343.25M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $336.68M 10-K · filed 2023-03-30 | $336.56M 10-K · filed 2022-03-16 |
| 2021-09-30 | $339.22M 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $339.12M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $339.02M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $240.82M 10-K · filed 2022-03-16 | |
| 2020-09-30 | $236.32M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $234.86M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $233.74M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $232.58M 10-K · filed 2021-03-04 | |
| 2019-09-30 | $232.49M 10-Q · filed 2019-11-04 | |
| 2019-06-30 | $232.21M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $231.82M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $230.75M 10-K · filed 2020-02-20 | |
| 2018-09-30 | $200.81M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $194.19M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $193.23M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $192.67M 10-K · filed 2019-02-27 | $192.54M 10-K · filed 2018-02-22 |
| 2017-09-30 | $192.04M 10-Q · filed 2017-11-01 | |
| 2017-06-30 | $183.84M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $177.33M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $175.76M 10-K · filed 2018-02-22 | |
| 2016-09-30 | $165.09M 10-Q · filed 2016-11-01 | |
| 2016-06-30 | $163.51M 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $161.79M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $160.74M 10-K · filed 2017-03-02 | |
| 2015-09-30 | $159.57M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $113.29M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $111.70M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $110.53M 10-K · filed 2016-03-10 | |
| 2014-09-30 | $98.26M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $97.65M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $96.80M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $96.43M 10-K · filed 2015-03-16 | |
| 2013-09-30 | $83.36M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $83.02M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $82.61M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $81.92M 10-K · filed 2014-03-31 | |
| 2012-09-30 | $62.25M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $61.76M 10-Q/A · filed 2012-09-11 | |
| 2012-03-31 | $60.95M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $58.90M 10-K · filed 2013-04-16 | |
| 2011-09-30 | $57.10M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $56.68M 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $47.28M 10-K/A · filed 2012-05-11 | $47.28M 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |